Novel tracer for prostate cancer improves sensitivity
A new radiotracer, FACBC, may help identify presence or absence of focal neoplastic involvement in patients with prostate cancer, according to work conducted at Emory University.
A new radiotracer, FACBC, may help identify presence or absence of focal neoplastic involvement in patients with prostate cancer, according to work conducted at Emory University. Researchers using the tracer demonstrated its uptake in both primary and metastatic prostate cancer on initial staging, as well as in recurrent cancer within the prostate bed, lymph nodes, and bone. The findings were reported in the January issue of the Journal of Nuclear Medicine.
Dr. David M. Schuster and colleagues evaluated nine patients with a recent diagnosis of prostate cancer and six with suspected recurrence. In eight of the newly diagnosed patients who underwent dynamic scanning, visual analysis correctly identified the presence or absence of focal neoplastic involvement in 40 of 48 prostate sextants. Pelvic nodal status correlated with FACBC findings in seven of nine patients and was indeterminate in two.
In all four patients with proven recurrence, researchers identified disease. In three of these patients, indium-111 ProstaScint had no significant uptake at nodal and skeletal foci.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
